Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart attack study halted: could conditioning the heart and arm help?

NCT ID NCT03155022

Terminated Disease control Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether using two types of 'ischemic conditioning' (brief cycles of blood flow restriction and release) could improve outcomes for people having a major heart attack. One method used a blood pressure cuff on the arm, the other used a balloon inside the heart artery during stent placement. The trial was stopped early, so we don't have clear answers on whether this combined approach helps patients recover better.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ischemic conditioning (remote and intracoronary)
What this could lead to
If it had succeeded, this approach could have pointed toward a way to reduce heart damage and improve recovery after a heart attack.
What could go wrong
The trial was terminated early, so results are limited. It is unclear if the combined conditioning provides any real benefit, and the approach may not work for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOCARDIAL INFARCTION, ACUTE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myocardial infarction myocardial infarction ST-elevation myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYOCARDIAL INFARCTION, ACUTE

Contacts and locations

Locations

  • Algemeen Ziekenhuis Sint Jan

    Bruges, Belgium

  • CHU de Charleroi

    Charleroi, Belgium

  • Hopital Louis Pradel

    Bron, France

  • Universitair Ziekenhuis Antwerpen

    Edegem, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.